NASDAQ : CDIO
Cardio Diagnostics Holdings, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 1.67 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.94M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 4.94M |
| Enterprise Value | -274,686 |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 2.96M |
| Shares Outstanding | 2.96M |
| Shares Change (YoY) | +68.88% |
| Shares Change (QoQ) | +4.18% |
| Owned by Insiders (%) | 4.14% |
| Owned by Institutions (%) | 6.52% |
| Float | 2.84M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 342.03 |
| Forward PS | n/a |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 17.15 |
| Quick Ratio | 15.56 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -525.07 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -75.44% |
| Return on Assets (ROA) | -44.06% |
| Return on Invested Capital (ROIC) | -44.49% |
| Return on Capital Employed (ROCE) | -85.34% |
| Weighted Average Cost of Capital (WACC) | 15.59% |
| Revenue Per Employee | $850 |
| Profits Per Employee | -$380,561 |
| Employee Count | 17 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.24 |
| 52-Week Price Change | -59.31% |
| 50-Day Moving Average | 1.87 |
| 200-Day Moving Average | 2.07 |
| Relative Strength Index (RSI) | 41.04 |
| Average Volume (20 Days) | 25,417 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2,971 |
| Short Previous Month | 1,012 |
| Short % of Shares Out | 0.10% |
| Short % of Float | 0.10% |
| Short Ratio (days to cover) | 0.09 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 14,450 |
| Gross Profit | 14,450 |
| Operating Income | -6.46M |
| Pretax Income | -6.47M |
| Net Income | -6.47M |
| EBITDA | -6.08M |
| EBIT | -6.46M |
| Loss Per Share | -$2.76 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 5.59M |
| Total Debt | 369,698 |
| Net Cash | 5.22M |
| Net Cash Per Share | $1.76 |
| Equity (Book Value) | 7.43M |
| Book Value Per Share | 2.51 |
| Working Capital | 5.80M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -5.66M |
| Capital Expenditures | -164,594 |
| Depreciation & Amortization | 373,758 |
| Net Borrowing | -346,481 |
| Free Cash Flow | -5.82M |
| FCF Per Share | -$1.97 |
Margins
| Measure | Value |
|---|
| Gross Margin | 100.00% |
| Operating Margin | -44,690.68% |
| Pretax Margin | -44,771.83% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -68.88% |
| Shareholder Yield | -68.88% |
| Earnings Yield | -165.18% |
| FCF Yield | -117.85% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 13, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.24 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |